Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5951377 | Atherosclerosis | 2010 | 5 Pages |
Abstract
APOH plasma concentrations are strongly associated to MS alterations and vascular disease in type 2 diabetic patients and could be considered as a clinical marker of cardiovascular risk. The enhanced APOH levels in these patients are due to an increased liver synthesis. If APOH plays a major causal role in macrovascular lesions associated to diabetes and MS need further studies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Antoni Castro, Iolanda Lázaro, David M. Selva, Ela Céspedes, Josefa Girona, NúriaPlana NúriaPlana, Montse Guardiola, Anna Cabré, Rafael Simó, LluÃs Masana,